AdvaMed Position Statement Regarding Transition to National Reimbursement Codes
AdvaMed understands there has been some confusion surrounding our member plans to transition away from the acronyms NDC/NHRIC (National Drug Code/National Health Related Items Code) to National Reimbursement Code (NRC). This AdvaMed position statement is intended to provide clarity about the transition, including rationale and implications.
Related Reading
News / Coverage & Payment / Government & Legislative Affairs
AdvaMed Applauds Ongoing Congressional Efforts to Address Coverage for Breakthrough Technologies
September 19, 2023
Today, following a legislative hearing on improving seniors’ access to innovative medical devices and technologies, AdvaMed President and CEO Scott Whitaker commended the House Energy and Commerce Committee’s Subcommittee on Health for hosting the panel.
News / Coverage & Payment
AdvaMed Proposes Comprehensive Strategy to Improve Medicare Beneficiaries’ Access to Artificial Intelligence and other Software Tools
August 30, 2023
AdvaMed, the Medtech Association, and CapView Strategies released a white paper detailing ways to help advance the ethical incorporation of innovative artificial intelligence (AI) and software solutions into Medicare coverage and payment policies.
Event / Legal / Regulatory Affairs
16th Annual King & Spalding Medical Device Summit
September 7, 2023
8:00 AM – 5:00 PM
Register for the 16th Annual King & Spalding Medical Device Summit in Chicago!
News / Coverage & Payment
In Comments to CMS, AdvaMed Urges Agency to Finalize Breakthrough Coverage Pathway, Offers Recommendations to Fully Leverage TCET
August 29, 2023
AdvaMed, the Medtech Association, submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the Transitional Coverage for Emerging Technologies (TCET) notice.
News / Coverage & Payment / Government & Legislative Affairs
AdvaMed Leads Medtech Industry in Opposing Medicare Cuts Impacting Patient Access to Specialty Care
August 22, 2023
This week, AdvaMed, the Medtech Association, sent a letter to Congressional leaders regarding the proposed payment cuts to office-based specialist physicians under the Medicare Physician Fee Schedule. AdvaMed was joined on the letter to Senate Majority Leader Schumer, Senate Minority Leader McConnell, Speaker McCarthy, and House Minority Leader Jeffries by the Medical Device Manufacturers Association and the Medical Imaging and Technology Alli
Resource / Coverage & Payment
Medicare Policy at the Crossroads: Addressing Artificial Intelligence and Software
August 21, 2023
Medicare beneficiaries stand to gain greatly from the ethical development and use of artificial intelligence (AI) and software solutions that improve the diagnosis and treatment of illness and disability, promote healthy behaviors, and support population health management. Advancements in quality, health outcomes, and health system savings can be achieved with access to these innovations.
Blog / Coverage & Payment / Ethylene Oxide / Global & Trade / Government & Legislative Affairs / Investor Relations / Regulatory Affairs
Building Medtech Connections and Why They Matter
August 18, 2023
Scott Whitaker, president and CEO of AdvaMed, recently chatted with Joe Mullings, chairman and CEO of The Mullings Group, about the impact of the medtech industry and the importance of connections.
Event / Regulatory Affairs
Are You Recall Ready? Exploring Solutions that Can Help You be Ready and Agile.
September 19, 2023
10:30 AM – 11:30 AM
Gear up for success with the “Recall Rediness” webinar by IQVIA & AdvaMed. Learn how to ease internal loads, ensuring efficient and compliant recalls.